NAKAMURA, T.; MIYAMOTO, T.; TANADA, D.; NISHII, R.; OKAMURA, S.; INUI, T.; DOI, Y.; TANAKA, K.; YANAI, M.; HIROSE, M.; KIMURA, T. Initial dose of tapentadol and concomitant use of duloxetine are associated with delirium occurring after initiation of tapentadol therapy in cancer patients. Journal of Opioid Management, [S. l.], v. 20, n. 6, p. 495–502, 2024. DOI: 10.5055/jom.0859. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/3746. Acesso em: 22 dec. 2024.